RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
  CTVS
  Plastic Surgery
  Transplantation
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
CTVS Channel

subscribe to CTVS newsletter
Latest Research : Surgery : CTVS

   EMAIL   |   PRINT
Bypass surgery free of long-term Brain effects

Apr 25, 2005 - 7:38:00 PM
"In this paper, we reassessed what we think we know about cognitive decline attributable to the use of cardiopulmonary bypass versus cognitive decline due to pre-existing vascular disease of the brain. Just about everyone agrees that some patients do suffer cognitive decline after CABG, but almost nobody agrees on how serious this decline is, and how long it lasts."

 
[RxPG] A broad retrospective review of the effects of coronary artery bypass grafting (CABG) on memory and other brain functions concludes that, while there may be transient short-term effects, the procedure itself probably does not cause late or permanent neurological effects.

In an article published online April 25, 2005, in the Annals of Neurology (www.interscience.wiley.com/journal/ana), the authors argue that the late cognitive declines seen in some long-term studies are likely associated with progression of underlying conditions such as cerebrovascular disease rather than the surgery itself.

"We think that there are short-term cognitive changes after CABG in a subset of patients, but absent a frank stroke, these changes are generally mild and transient," said author Ola Selnes, Ph.D., professor of neurology at Johns Hopkins Hospital in Baltimore, Maryland. "We believe most patients who experience cognitive decline will return to their baseline by three months or sooner."

The exceptions, according to Selnes, might include older patients and those with risk factors for cerebrovascular disease or a history of stroke.

In their review article, Selnes and co-author Guy M. McKhann, M.D., also of Johns Hopkins, surveyed the published studies on cognitive changes following CABG. Confusing the issue, they point out, is the variability in the way this question has been approached.

Selnes and McKhann note that the surgical procedure itself varies among different institutions and surgeons. Similarly, there is wide variance in study populations and control groups, follow-up periods, and statistical analysis.

It is curious, the authors note, that studies should continue to find cognitive deficits despite the fact that CABG is a procedure in evolution, with surgical and anesthesiological techniques improving vastly over the past decades. This may be due in part to the reality that the population having the surgery is becoming older and sicker, with more hypertension, diabetes, previous strokes, and other disorders.

"In this paper, we reassessed what we think we know about cognitive decline attributable to the use of cardiopulmonary bypass versus cognitive decline due to pre-existing vascular disease of the brain," said Selnes. "Just about everyone agrees that some patients do suffer cognitive decline after CABG, but almost nobody agrees on how serious this decline is, and how long it lasts."

The authors find that the existing literature confirms the existence of mild deficits in the period up to three months after surgery, possibly due to minor disruption in blood flow that can be result from any major surgery, or other factors associated with surgery such as inflammation or complications of anesthesia.

But when they looked closely at the most authoritative studies -- those with appropriate control groups -- the authors failed to find strong evidence that cognitive deficits persist after three months in most patients.

"We believe that patients should not be discouraged from having CABG because of the risk of late cognitive decline," said Selnes.

He adds that their review emphasizes the need to have an appropriate control group when looking at cognitive outcomes after a surgical procedure.



Publication: Article: "Neurocognitive Complications after Coronary Artery Bypass Surgery," Ola A. Selnes and Guy M. McKhann, Annals of Neurology; Published Online: April 25, 2005 (DOI: 10.1002/ana.20481)
On the web: www.aneuroa.org 

Advertise in this space for $10 per month. Contact us today.


Related CTVS News
Clopidogrel does not increase postoperative bleeding risk in patients with Acute Coronary Syndrome
AAAs are best operated at large centres - study suggests
'Off-pump' CABG appears to have no benefit on cognitive or cardiac outcomes at 5 years
Minimally invasive approach and a revolutionary device to treat thoracic aortic aneurysm
Cox-maze IV: New simpler technique for persistent Atrial Fibrillation
Nesiritide may be beneficial in the prevention of renal dysfunction after CABG
Aprotinin use during CABG associated with increased mortality rates
Mayo Clinic surgeons propose a system of quality indicators for lung surgery
Off-pump CABG is a safer option
Off-pump CABG is a safer option

Subscribe to CTVS Newsletter

Enter your email address:


 Additional information about the news article
The Annals of Neurology, the preeminent neurological journal worldwide, is published by the American Neurological Association, the world's oldest and most prestigious neurological association. The 1,500 members of the ANA--selected from among the most respected academic neurologists and neuroscientists in North America and other countries--are devoted to furthering the understanding and treatment of nervous system disorders. For more information, visit www.aneuroa.org.
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)